-+ 0.00%
-+ 0.00%
-+ 0.00%

*Allogene Therapeutics Plans to Use Net Proceeds From Offering for General Corporate Purposes, Capital Expenditure >ALLO

Dow Jones·04/15/2026 01:59:00

Please log in to view news